1. Home

Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template

NICE process and methods [PMG24] Published: 08 January 2015 Last updated: 10 February 2022

  • Process
  • Tools and resources
  • Instructions for companies
  • Appendix C: Summary of product characteristics (SmPC) or information for use (IFU) and UK public assessment report, scientific discussion or drafts
  • Appendix D: Identification, selection and synthesis of clinical evidence
  • Appendix E: Subgroup analysis
  • Appendix F: Adverse reactions
  • Appendix G: Published cost-effectiveness studies
  • Appendix H: Health-related quality-of-life studies
  • Appendix I: Cost and healthcare resource identification, measurement and valuation
  • Appendix J: Clinical outcomes and disaggregated results from the model
  • Appendix K: Price details of treatments included in the submission
  • Appendix L: Checklist of confidential information
Download (PDF)

Tools and resources

Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission appendices

  • Next

Appendix E: Subgroup analysis

Appendix E: Subgroup analysis

Provide a summary of the results for the subgroups in appendix E.

See section 2.7 of the main user guide for company evidence submission for full details of the information required here.


This page was last updated: 10 February 2022

  • Next